The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
Initially developed for obesity treatment, AOD9604 showed weight-reducing effects in rodent models comparable to those of full-length GH, but without inducing diabetes or stimulating IGF-1 production
Ive been using the B12 injections for 2 weeks and I feel great
No universal dose: appropriate use depends on an individuals health profile and is determined by a licensed provider, not a standard number from the internet
Researchers who have tried GHK-Cu for hair without satisfactory results sometimes switch to AHK-Cu
Species-specific factors profoundly influence both efficacy and safety profiles